Based on these thresholds, the assay can be used for the robust quantification of ERBB2, ESR1, PGR and MKI67 on whole sections of FFPE samples during routine histopathological work-up of breast carcinoma. This evidence concerns the gene ERBB2 and breast carcinoma.